Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology

E-ISSN： 1873-4286|23|32|4893-4905

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.32, 2017-12, pp. : 4893-4905

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Interleukin-1&bgr; for Pain

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 571-575

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting nanotherapeutics to the tumor microenvironment: how accurately can we aim?

By Schroeder Avi

Therapeutic Delivery, Vol. 4, Iss. 7, 2013-07 ,pp. : 771-773

Future Science

Access to resources Recommend Favorite

Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 486-499

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4703-4704

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the LKB1 Tumor Suppressor

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 32-52

Bentham Science Publishers

Access to resources Recommend Favorite